Requip and Zolpidem tartrate drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Requip and Zolpidem tartrate. Common interactions include gastric ulcer among females and dizziness among males.
The phase IV clinical study analyzes what interactions people who take Requip and Zolpidem tartrate have. It is created by eHealthMe based on reports of 124 people who take Requip and Zolpidem tartrate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
124 people who take Requip and Zolpidem tartrate together, and have interactions are studied.
What is Requip?
Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 22,097 Requip users for its effectiveness, alternative drugs and more.
What is Zolpidem tartrate?
Zolpidem tartrate has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 28,221 Zolpidem tartrate users for its effectiveness, alternative drugs and more.
Number of Requip and Zolpidem tartrate reports submitted per year:
Requip and Zolpidem tartrate drug interactions by gender *:
Requip and Zolpidem tartrate drug interactions by age *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Requip and Zolpidem tartrate?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Hsu FG, Sheu MJ, Lin CL, Hsieh YW, Lai SW, "Use of Zolpidem and Risk of Acute Pyelonephritis in Women: A Population‐Based Case‐Control Study in Taiwan", The Journal of Clinical Pharmacology, 2017 Mar .
- Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .
- Sun Y, Lin CC, Lu CJ, Hsu CY, Kao CH, "Association between zolpidem and suicide: a nationwide population-based case-control study", InMayo Clinic Proceedings, 2016 Mar .
- Liao KF, Lin CL, Lai SW, Chen WC, "Zolpidem use associated with increased risk of pyogenic liver abscess: a case-control study in Taiwan", Medicine, 2015 Jan .
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
- Requip (22,097 reports)
- Zolpidem tartrate (28,221 reports)
Common Requip and Zolpidem tartrate interactions:
- Drug ineffective: 4 reports
Browse all drug interactions of Requip and Zolpidem tartrate:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Requip side effects:
- Drug ineffective: 1,870 reports
- Fatigue (feeling of tiredness): 1,331 reports
- Drowsiness: 1,164 reports
- Dizziness: 1,134 reports
- Pain: 1,043 reports
Browse all side effects of Requip:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Zolpidem tartrate side effects:
- Drug ineffective: 1,817 reports
- Fatigue (feeling of tiredness): 1,364 reports
- Insomnia (sleeplessness): 1,284 reports
- Diarrhea: 1,084 reports
- Stress and anxiety: 1,063 reports
- Headache (pain in head): 1,022 reports
Browse all side effects of Zolpidem tartrate:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Requip interactions:
- Requip and Aspirin: 2,449 reports
- Requip and Sinemet: 1,967 reports
- Requip and Gabapentin: 1,668 reports
- Requip and Lasix: 1,564 reports
- Requip and Lyrica: 1,561 reports
- Requip and Lisinopril: 1,558 reports
- Requip and Synthroid: 1,505 reports
- Requip and Cymbalta: 1,494 reports
- Requip and Lipitor: 1,409 reports
- Requip and Neurontin: 1,258 reports
Browse all interactions between Requip and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Zolpidem tartrate interactions:
- Zolpidem tartrate and Omeprazole: 2,594 reports
- Zolpidem tartrate and Gabapentin: 2,518 reports
- Zolpidem tartrate and Aspirin: 2,419 reports
- Zolpidem tartrate and Alprazolam: 2,298 reports
- Zolpidem tartrate and Furosemide: 2,172 reports
- Zolpidem tartrate and Lorazepam: 2,065 reports
- Zolpidem tartrate and Amlodipine: 1,892 reports
- Zolpidem tartrate and Prednisone: 1,871 reports
- Zolpidem tartrate and Tramadol: 1,808 reports
- Zolpidem tartrate and Lisinopril: 1,718 reports
Browse all interactions between Zolpidem tartrate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on ropinirole hydrochloride and zolpidem tartrate (the active ingredients of Requip and Zolpidem tartrate, respectively), and Requip and Zolpidem tartrate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Requip and Zolpidem tartrate.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- How effective is Fetzima for Bipolar Ii Disorder? - 4 seconds ago
- Sodium Bicarbonate In Plastic Container and Heparin Sodium drug interaction - 5 seconds ago
- Requip Xl and Skin Discoloration - 5 seconds ago
- Thrush in Omeprazole, how severe and when it was recovered? - 8 seconds ago
- Cerebral Ischaemia and Hemiplegia - 17 seconds ago
- Revatio and Total Lung Capacity Decreased - 23 seconds ago
- Pomalyst and Pneumonia Parainfluenzae Viral - 24 seconds ago
- Androgel and Ninlaro drug interaction - 25 seconds ago
- Yervoy and Mobility Decreased - 29 seconds ago
- Sulfamethoxazole And Trimethoprim and Medical Device Complication - 35 seconds ago